Marvell Technology(MRVL)
Search documents
Marvell Announces Immediate Availability of Open Ecosystem Software for Teralynx 10 51.2T Switch
Prnewswire· 2024-07-25 13:05
Marvell ® Teralynx ® 10 switch now available in Linux Foundation's open-source SONiC, capitalizing on market shift to open network platforms SANTA CLARA, Calif., July 25, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today announced the immediate availability of the Marvell® Teralynx® 10 51.2 Tbps Ethernet switch device in the Linux Foundation's SONiC (Software for Open Networking in the Cloud) network operating system. With this publi ...
Marvel Announces an Extension to Its Collaboration with The iBraiN Institute to Test MB204 In a Pre-Clinical Model of Rett Syndrome
Newsfile· 2024-07-24 13:00
Marvel Announces an Extension to Its Collaboration with The iBraiN Institute to Test MB204 In a Pre-Clinical Model of Rett SyndromeJuly 24, 2024 9:00 AM EDT | Source: Marvel Biosciences Corp.Calgary, Alberta--(Newsfile Corp. - July 24, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), today is pleased to announce the extension of its collaboration with Drs. Julie Le Merrer and Jerom ...
Wall Street Bulls Look Optimistic About Marvell (MRVL): Should You Buy?
ZACKS· 2024-07-22 14:36
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about Marvell Technology (MRVL) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Marvell currently has a ...
Marvel Biosciences Closes Private Placement
Newsfile· 2024-07-19 13:00
Calgary, Alberta--(Newsfile Corp. - July 19, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to report that, further to its press releases of May 16, 2024 and June 21, 2024, it has closed its non-brokered private placement unit offering (the "Offering"). The offering resulted in the issuance of 5,000,000 units at $0.10 per unit (the "Units") for gross proceeds of $500,000. Each Unit is comprised of ...
Marvell Technology: Severely Underappreciated In Round #2 Of AI Chip Wars
Seeking Alpha· 2024-07-10 05:57
BlackJack3D Investment Thesis Marvell Technology (NASDAQ:MRVL) is still suffering from the cold it caught a few years ago due to the slowdown in some of its erstwhile growth markets, such as carrier infrastructure and automotive connectivity solutions. On a year-to-date basis, Marvell is still marginally outperforming broader markets, delivering 22% in 2024 versus the 17–22% performance range of the indices, but still underperforming the Philly Semiconductor Index (SOX). Exhibit A: Marvell's performan ...
1 Top Chip Stock Reporting Massive AI Growth -- Why Isn't the Stock Rising?
The Motley Fool· 2024-07-02 08:45
Marvell has all the pieces in place to rival the best AI chip designers, but it's underperforming nonetheless.After a solid rally in 2023 and a hot start to 2024, shares of chip designer Marvell Technology Group (MRVL 1.57%) have failed to participate in the artificial intelligence (AI) chip stock surge this year. It's a confounding situation, because Marvell has many of the pieces in place to rival one of the top semiconductor stocks right now, Broadcom (AVGO 2.20%). Is there something wrong with Marvell? ...
Marvell Technology (MRVL) Upgrades Its Alaska Portfolio
ZACKS· 2024-06-28 12:45
Marvell Technology (MRVL) shares have climbed 14% year to date, reflecting investors’ confidence in the company’s strong financials and innovative product line.MRVL is benefiting from robust demand across its electro-optics portfolio, which includes pulse amplitude modulation (“PAM”), digital signal processors (“DSP”), trans-impedance amplifiers and ZR data center interconnect products.Adding to its wide array of electro-optics portfolio, Marvell Technology has launched the Alaska A 1.6T PAM4 DSP for active ...
Marvell Extends Connectivity Leadership With Industry's First 1.6T PAM4 DSP for Active Electrical Cables
Prnewswire· 2024-06-27 13:00
New Alaska® A 1.6T PAM4 DSP for copper interconnects is built on Marvell industry-leading 5nm PAM4 technology. Addresses the growing need for 200G/lane I/O to handle AI accelerator and GPU bandwidth demands. Enables 1.6T short-reach copper connectivity within accelerated compute racks. SANTA CLARA, Calif., June 27, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today introduced the Marvell® Alaska® A 1.6T PAM4 DSP for active electric ...
Marvell Technology, Inc. Declares Quarterly Dividend Payment
Prnewswire· 2024-06-21 20:05
SANTA CLARA, Calif., June 21, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), today announced a quarterly dividend of $0.06 per share of common stock payable on July 31, 2024 to shareholders of record as of July 12, 2024.About MarvellTo deliver the data infrastructure technology that connects the world, we're building solutions on the most powerful foundation: our partnerships with our customers. Trusted by the world's leading technology companies for over 25 years, we move, store, process and ...
Marvel Biosciences Announces Private Placement Update
Newsfile· 2024-06-21 19:55
Calgary, Alberta--(Newsfile Corp. - June 21, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), wishes to announce that, further to Marvel's May 16, 2024 press release announcing the Company's non-brokered private placement unit offering (the "Offering"), the TSX Venture Exchange ("TSXV" or the "Exchange") has conditionally accepted the Company's proposed Offering and has granted the Company a two-week extension ...